Literature DB >> 18380994

Treatment of tobacco dependence.

Michael V Burke1, Jon O Ebbert, J Taylor Hays.   

Abstract

Cigarette smoking continues to cause substantial death and disability, but more than 1 in 5 adults smoke despite the desire among most smokers to stop and the availability of effective treatments. A systematic process to identify all smokers is crucial. Because tobacco dependence is characterized by relapses and remissions, clinicians should be ready to engage smokers and reengage relapsed smokers with options for new medication strategies and additional counseling resources.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18380994     DOI： 10.4065/83.4.479

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


  9 in total

1.  A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence.

Authors:  Sunmee Wee; Leandro F Vendruscolo; Kaushik K Misra; Joel E Schlosburg; George F Koob
Journal:  Sci Transl Med       Date:  2012-08-08       Impact factor: 17.956

2.  A preliminary study suggests that nicotine and prefrontal dopamine affect cortico-striatal areas in smokers with performance feedback.

Authors:  M R Lee; C L Gallen; T J Ross; P Kurup; B J Salmeron; C A Hodgkinson; D Goldman; E A Stein; M A Enoch
Journal:  Genes Brain Behav       Date:  2013-04-11       Impact factor: 3.449

Review 3.  Zebrafish for the study of the biological effects of nicotine.

Authors:  Eric W Klee; Jon O Ebbert; Henning Schneider; Richard D Hurt; Stephen C Ekker
Journal:  Nicotine Tob Res       Date:  2011-03-08       Impact factor: 4.244

Review 4.  Nicotine and the adolescent brain.

Authors:  Menglu Yuan; Sarah J Cross; Sandra E Loughlin; Frances M Leslie
Journal:  J Physiol       Date:  2015-06-23       Impact factor: 5.182

5.  Pretreatment lifestyle behaviors as survival predictors for patients with nasopharyngeal carcinoma.

Authors:  Guo-Ping Shen; Feng-Hua Xu; Fen He; Hong-Lian Ruan; Cui Cui; Li-Zhen Chen; Yi-Xin Zeng; Wei-Hua Jia
Journal:  PLoS One       Date:  2012-05-08       Impact factor: 3.240

6.  Impact of a Smoking Cessation Quitline in Vietnam: Evidence Base and Future Directions.

Authors:  Chau Quy Ngo; Phuong Thu Phan; Giap Van Vu; Quyen Thi Le Pham; Hanh Thi Chu; Kiet Tuan Huy Pham; Bach Xuan Tran; Huyen Phuc Do; Cuong Tat Nguyen; Tung Thanh Tran; Giang Hai Ha; Anh Kim Dang; Huong Thi Lan Nguyen; Carl A Latkin; Cyrus S H Ho; Roger C M Ho
Journal:  Int J Environ Res Public Health       Date:  2019-07-16       Impact factor: 3.390

Review 7.  Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.

Authors:  Jon O Ebbert; Kirk D Wyatt; Ali Zirakzadeh; Michael V Burke; Jt Hays
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29

8.  Correlated Factors with Quitting Attempts Among Male Smokers in Vietnam: A QUITLINE-Based Survey.

Authors:  Chau Quy Ngo; Ryan G Chiu; Hanh Thi Chu; Giap Van Vu; Quang Nhat Nguyen; Long Hoang Nguyen; Tung Thanh Tran; Cuong Tat Nguyen; Bach Xuan Tran; Carl A Latkin; Cyrus S H Ho; Roger C M Ho
Journal:  Int J Environ Res Public Health       Date:  2018-12-30       Impact factor: 3.390

9.  Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial.

Authors:  Edward F Ellerbeck; Nicole Nollen; Tresza D Hutcheson; Milind Phadnis; Sharon A Fitzgerald; James Vacek; Matthew R Sharpe; Gary A Salzman; Kimber P Richter
Journal:  JAMA Netw Open       Date:  2018-09-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.